Literature DB >> 16681963

[Long-term results of percutaneous sonographically-guided microwave ablation therapy of early-stage hepatocellular carcinoma].

Bao-wei Dong1, Ping Liang, Xiao-ling Yu, De-jiang Yu, Jing Zhang, Lei Feng, Zhi-gang Cheng, Yang Wang, Zhi-li Wang.   

Abstract

OBJECTIVE: To evaluate the long-term results of percutaneous microwave coagulation therapy in the treatment of early hepatocellular carcinoma.
METHODS: From May 1994 to June 2004, a total of 216 patients with 275 nodules of hepatocellular carcinoma whose diameter <or= 5 cm had undergone percutaneous microwave coagulation therapy (193 men, 23 women; mean age, 54.68 years). Institute review board approval and informed consent were obtained. Complete tumor necrosis rates, long-term survival rates, recurrence rates and the complications of the patients were analyzed.
RESULTS: The mean follow-up period after microwave ablation was 40 months +/- 24 (range, 6 - 127 months). One hundred fifty-nine remained alive and consulted our hospital periodically as outpatients. Fifty-seven patients died. Complete tumor necrosis was seen in 95.64% (263/275) patients. One, 2, 3, 4 and 5-year cumulative survival rates were 94.87%, 88.81%, 80.44%, 74.97% and 68.63%, respectively. One, 2, 3, 4 and 5-year cumulative recurrence rates were 20.01%, 32.04%, 39.57%, 44.97% and 52.90%, respectively. Three patients have severe complications, including needle track implantation in one patient, biliary fistula in two patients. One patient died of pulmonary infection one week after the treatment.
CONCLUSION: Sonographically-guided microwave coagulation therapy could make complete tumor necrosis in most cases of early hepatocellular carcinoma with low incidence of complications and this method has satisfactory long-term curative effect.

Entities:  

Mesh:

Year:  2006        PMID: 16681963

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  7 in total

1.  Guidelines for power and time variables for microwave ablation in a porcine liver.

Authors:  William W Hope; Thomas M Schmelzer; William L Newcomb; Jessica J Heath; Amy E Lincourt; H James Norton; B Todd Heniford; David A Iannitti
Journal:  J Gastrointest Surg       Date:  2007-09-06       Impact factor: 3.452

Review 2.  Ablation therapy for hepatocellular carcinoma: past, present and future perspectives.

Authors:  David J Niemeyer; Kerri A Simo; David A Iannitti; Iain H McKillop
Journal:  Hepat Oncol       Date:  2013-12-20

3.  Contrast-enhanced ultrasound is better than magnetic resonance imaging in evaluating the short-term results of microwave ablation treatment of uterine fibroids.

Authors:  Yan Zhang; Meiwu Zhang; Xiaoxiang Fan; Dafeng Mao
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

4.  Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial.

Authors:  David A Iannitti; Robert C G Martin; Caroline J Simon; William W Hope; William L Newcomb; Kelly M McMasters; Damian Dupuy
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 5.  Liver ablation techniques: a review.

Authors:  N Bhardwaj; A D Strickland; F Ahmad; A R Dennison; D M Lloyd
Journal:  Surg Endosc       Date:  2009-06-25       Impact factor: 4.584

6.  Local Tumor Progression of Hepatocellular Carcinoma After Microwave Percutaneous Ablation: A Preliminary Report.

Authors:  Franco Brunello; Patrizia Carucci; Silvia Gaia; Emanuela Rolle; Paola Rita Brunocilla; Anna Castiglione; Giovannino Ciccone; Mario Rizzetto
Journal:  Gastroenterology Res       Date:  2012-01-20

7.  Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma.

Authors:  Lei Zhang; Neng Wang; Qiang Shen; Wen Cheng; Guo-Jun Qian
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.